0 results for 'Davis Polk'
Clifford Chance bolsters Hong Kong litigation group with former SFC director
Jimmy Chan joins CC's Hong Kong office after 14 years with the city's securities regulator
Wilson Sonsini, Davis Polk Handle China Biologic's $590M Share Sale
The share sale comes after the Chinese biopharmaceutical company rejected a $3.9 billion offer from a consortium led by its former CEO, David Gao, who said legal action may be taken against the company he once led from 2012 until June.
Hong Kong's Deacons Hires Ex-Davis Polk Capital Markets Pro
Former Davis Polk counsel Peter Cheng joins Deacons as the Hong Kong firm expects more listings in the city.
Clifford Chance Bolsters Hong Kong Litigation Group With Former SFC Director
Jimmy Chan has joined Clifford Chance's Hong Kong office as a partner after 14 years with the city's securities regulator.
Covington Partner Is Denied ZTE Monitorship Over 'Never Trump' Letter: Report
Peter Lichtenbaum, who co-chairs Covington's international trade and finance practice, was among 50 signatories on the "Never Trump" August 2016 letter. U.S. Commerce officials have reportedly chosen former U.S. attorney Roscoe Howard to lead the ZTE compliance monitor team.
Asia Deal Digest: Aug. 23, 2018
• Allens, KWM act on CK Infrastructure's $9.5 billion Australia infrastructure bid. • Skadden, Latham on Chinese electric vehicle startup's $1.8 billion U.S. IPO. • MoFo represents Japanese cigarette maker on $1.5 billion Bangladesh deal.
Are Wall Street law firms built to handle today's financial services industry?
Three emerging trends in the financial sector have created a new competitive landscape for traditional capital markets-oriented firms
A crack in the wall: how Wall Street's elite firms are being put to the test
The once-impenetrable facade of some of the sturdiest law firms in the US is showing signs of wear in the face of shifting financial markets. Now these firms are being forced to confront a once-foreign concept: competition.
Asia Deal Digest: August 9, 2018
• Freshfields, Clifford Chance act on Sinochem Energy's $2 billion initial public offering. • Skadden, Davis Polk on Hong Kong's first dual-primary listing. • Sidley Austin, Paul Hastings on the first pre-revenue biotech company to float in Hong Kong.
Three top firms to take cut of £20m in fees for work on 21st Century Fox's £24.5bn Sky bid
Fees for firms including Allen & Overy set out in 21st Century Fox's formal offer documentTRENDING STORIES
More from ALM
- Morgan & Morgan Class Action Attorneys Detail Pathway to Success Within Cybersecurity and Data Privacy Practice 1 minute read
- Holwell Shuster & Goldberg Partners Leverage 'Hostile' Witnesses to Secure $101 Million Verdict Against Walmart 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Mike Andolina, Partner, White & Case 1 minute read
Resources
Countdown to Compliance: SEC Private Fund Reforms
Brought to you by Ontra
Download Now
Top 10 Compliance Concerns for Private Fund Managers
Brought to you by Ontra
Download Now
The Top 10 Terms in Private Equity NDAs
Brought to you by Ontra
Download Now